Vimarsana
Biggest News Aggregation in the World

Page 10 - Skye Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Skye Bioscience Today - Breaking & Trending Today

SKYE BIOSCIENCE, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A) - Vimarsana News

SKYE BIOSCIENCE, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 16, 2023, Skye Bioscience,... | March 27, 2023

Skye Bioscience, Inc.: Skye Bioscience Receives Human Research Ethics Committee Approval to Start Multiple Ascending Dose Arm of Phase 1 Study of SBI-100 Ophthalmic Emulsion - Vimarsana News

Skye Bioscience, Inc.: Skye Bioscience Receives Human Research Ethics Committee Approval to Start Multiple Ascending Dose Arm of Phase 1 Study of SBI-100 Ophthalmic Emulsion

San Diego, California--(Newsfile Corp. - March 15, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative

Skye Bioscience moving ahead with SBI-100 clinical trial after positive safety review - Vimarsana News

Skye Bioscience moving ahead with SBI-100 clinical trial after positive safety review

Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman from the Proactive newsroom to discuss the positive safety review for its Phase 2 clinical trial...

Skye Bioscience, Inc.: Skye Bioscience Doses Second Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion - Vimarsana News

Skye Bioscience, Inc.: Skye Bioscience Doses Second Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion

San Diego, California--(Newsfile Corp. - February 13, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative

Skye Bioscience marks SBI-100 clinical trial progress with new clinical research organization - Vimarsana News

Skye Bioscience marks SBI-100 clinical trial progress with new clinical research organization

Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman from the Proactive studio to share the latest progress on its SBI-100 Ophthalmic Emulsion clinical...